eBand Nicotine Bracelet for Smarter, Healthier Smoking Cessation

Quitting smoking remains one of the most challenging health decisions, often requiring repeated attempts and a combination of treatment methods. The eBand presents a novel solution—an intelligent nicotine-delivery bracelet that actively monitors the body for withdrawal symptoms and administers medication only when necessary. By combining physiological biometrics and carbon nano-tube technology, this wearable aims to reduce dependence gradually while prioritizing safety, personalization, and user autonomy.

Personalized Nicotine Release Based on Biometrics

The eBand system employs a dual-parameter sensing method: blood pressure variability and changes in skin conductance. These indicators are scientifically linked to nicotine withdrawal and stress. When both signals deviate from an established baseline, the eBand interprets this as a withdrawal episode. In response, it releases a controlled micro-dose of nicotine or bupropion directly onto the skin using its nanochannel delivery system.

This personalized, responsive mechanism sets eBand apart from traditional methods like patches or gums, which operate on fixed schedules. Instead of exposing the user to constant nicotine, the eBand delivers it only when the body signals a need, supporting a gradual reduction of dependency. Users can view and analyze their withdrawal patterns via a mobile interface, enhancing their awareness and motivation to quit.

Advanced Carbon Nanotube Delivery and Smart Control

At the core of the eBand’s delivery mechanism lies a set of densely packed multiwalled carbon nanotubes (MWCTs). These nanochannels activate once a voltage threshold of 1.7 V is met. The electrical field causes a droplet of medication to transition from a superhydrophobic to a hydrophilic state, allowing it to pass through the MWCTs and be absorbed through the skin.

The system is powered by a compact, replaceable cartridge that connects with the device’s internal CPU and sensors. Users manage the bracelet through a companion app, adjusting sensitivity settings, reviewing intake data, and setting usage goals. The app also tracks long-term progress, helping users visualize the decline of physiological withdrawal responses over time.

Supported by Evidence and Designed for Success

eBand is designed to fit within clinically supported smoking cessation strategies. Nicotine replacement therapy (NRT) is a widely recognized approach, with success rates increasing significantly when combined with behavioral tracking and support. The estimated success rate of 35% offered by eBand reflects its integration of both pharmacological and behavioral treatment components.

In addition to its smart delivery, the eBand avoids the common downsides of other systems—no constant nicotine exposure, minimized risk of misuse, and a physical design that suits everyday use. Its cartridges are replaceable, and users can choose between nicotine or bupropion depending on their treatment needs. This flexibility supports a broad range of quitting journeys.

Healthier Approach Through Data-Driven Support

The eBand represents a modern, data-driven strategy to overcome smoking addiction. By measuring actual withdrawal signs and releasing medication accordingly, it creates a feedback loop that aligns with the body’s needs. Over time, the bracelet decreases the medication volume, promoting independence and eventual freedom from nicotine.

For those seeking an intelligent, supportive, and scientifically grounded method to quit smoking, eBand offers a new standard—merging medical technology, real-time monitoring, and user empowerment into a single wearable solution.